MedTrace Logo

SureCRIC Standardized Patient Study

NCT03488849 · Status: COMPLETED · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2021-11-23

Study results available
· View outcomes & findings →

Summary

SureCRIC is intended to be used as an accessory to cricothyrotomy and tracheotomy devices, helping to identify and stabilize anatomical landmarks for establishing an airway.

Cricothyroid membrane identification accuracy has been reported to be 30-62% in the literature \[Bai15, Ell10, Kri15, Lam15\]. The current study assesses SureCRIC-assisted medic performance in identifying the cricothyroid membrane in a diverse standardized patient population.

Conditions

  • Airway Obstruction

Interventions

DEVICE

SureCRIC

SureCRIC is intended to be used as an accessory to cricothyrotomy and tracheotomy devices, helping to identify and stabilize anatomical landmarks for establishing an airway.

OTHER

Freehand

Freehand palpation approach to identification of the cricothyroid membrane

Sponsors & Collaborators

  • Medstar Health Research Institute

    collaborator OTHER

  • InnoVital Systems, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-16
Primary Completion
2017-10-27
Completion
2017-10-27

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03488849 on ClinicalTrials.gov